{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:00:19Z","timestamp":1794535219776,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-1072-1","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:15:26Z","timestamp":1542975326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["miR-181b\/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC"],"prefix":"10.1186","volume":"9","author":[{"given":"Xiaoyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin C, Mariotto AB, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2014;64:252\u201371.","journal-title":"CA Cancer J Clin"},{"key":"1072_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","volume":"44","author":"DA Fennell","year":"2016","unstructured":"Fennell DA, Summers Y, Cadranel J, et al. Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Tre Rev. 2016;44:42\u201350.","journal-title":"Cancer Tre Rev"},{"key":"1072_CR3","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1158\/1535-7163.MCT-10-0397","volume":"9","author":"KE Allen","year":"2010","unstructured":"Allen KE, Weiss GJ. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther. 2010;9:3126\u201336.","journal-title":"Mol Cancer Ther"},{"key":"1072_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drup.2010.02.001","volume":"13","author":"FH Sarkar","year":"2010","unstructured":"Sarkar FH, Li Y, Wang Z, et al. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resis Updat. 2010;13:57\u201366.","journal-title":"Drug Resis Updat"},{"key":"1072_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs G, Paterson JK, Ludwig JA, et al. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"1072_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrc3184","volume":"12","author":"LV Nguyen","year":"2012","unstructured":"Nguyen LV, Vanner R, Dirks P, et al. Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012;12:133\u201343.","journal-title":"Nat Rev Cancer"},{"key":"1072_CR7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/stem.741","volume":"29","author":"N Bitarte","year":"2001","unstructured":"Bitarte N, Bandres E, Boni V, et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells. 2001;29:1661\u201371.","journal-title":"Stem Cells"},{"key":"1072_CR8","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.1158\/0008-5472.CAN-14-1140","volume":"74","author":"EY Park","year":"2014","unstructured":"Park EY, Chang E, Lee EJ, et al. Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. Cancer Res. 2014;74:7573\u201382.","journal-title":"Cancer Res"},{"key":"1072_CR9","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1038\/onc.2016.414","volume":"36","author":"ZM Shi","year":"2017","unstructured":"Shi ZM, Wang L, Shen H, et al. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug\/ZEB2 signaling. Oncogene. 2017;36:2577\u201388.","journal-title":"Oncogene"},{"key":"1072_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.prp.2013.04.018","volume":"209","author":"J Yang","year":"2013","unstructured":"Yang J, Liu H, Wang H, et al. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Pathol Res Pract. 2013;209:490\u20134.","journal-title":"Pathol Res Pract"},{"key":"1072_CR11","doi-asserted-by":"publisher","first-page":"17618","DOI":"10.1038\/srep17618","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang X, Chen X, Meng Q, et al. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFbetaR1\/Smad signaling pathway in NSCLC. Sci Rep. 2015;5:17618.","journal-title":"Sci Rep"},{"key":"1072_CR12","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/ijc.25260","volume":"127","author":"W Zhu","year":"2010","unstructured":"Zhu W, Shan X, Wang T, et al. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010;127:2520\u20139.","journal-title":"Int J Cancer"},{"key":"1072_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1674-8301(10)60058-9","volume":"24","author":"P Li","year":"2010","unstructured":"Li P, Lu X, Wang Y, et al. MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. J Bio Res. 2010;24:436\u201343.","journal-title":"J Bio Res"},{"key":"1072_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504\u201314.","journal-title":"Cell Death Differ"},{"key":"1072_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ejcts.2009.03.063","volume":"36","author":"V Tirino","year":"2009","unstructured":"Tirino V, Camerlingo R, Franco R, et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg. 2009;36:446\u201353.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1072_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275\u201384.","journal-title":"Nat Rev Cancer"},{"key":"1072_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1208\/s12248-009-9147-7","volume":"11","author":"JT DeSano","year":"2009","unstructured":"DeSano JT, Xu L. MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 2009;11:682\u201392.","journal-title":"AAPS J"},{"key":"1072_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"1072_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2016.01.012","volume":"372","author":"L MacDonagh","year":"2016","unstructured":"MacDonagh L, Gray SG, Breen E, et al. Lung cancer stem cells: the root of resistance. Cancer Let. 2016;372:147\u201356.","journal-title":"Cancer Let"},{"key":"1072_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"1072_CR21","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/jcb.26379","volume":"119","author":"X Bai","year":"2018","unstructured":"Bai X, Zhou Y, Yang M. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN. J Cell Biochem. 2018;119:2179\u201388.","journal-title":"J Cell Biochem"},{"key":"1072_CR22","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/1078-0432.CCR-17-1169","volume":"24","author":"X Hu","year":"2018","unstructured":"Hu X, Liu T, Wu X, et al. Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem cell-like phenotypes through repressing Wnt\/beta-catenin signaling. Clin Cancer Res. 2018;24:1748\u201360.","journal-title":"Clin Cancer Res"},{"key":"1072_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature04940","volume":"442","author":"A Androutsellis-Theotokis","year":"2006","unstructured":"Androutsellis-Theotokis A, Leker RR, Soldner F, et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature. 2006;442:823\u20136.","journal-title":"Nature"},{"key":"1072_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1582-4934.2007.00211.x","volume":"12","author":"AK Croker","year":"2008","unstructured":"Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cellular Mol Med. 2008;12:374\u201390.","journal-title":"J Cellular Mol Med"},{"key":"1072_CR25","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1158\/1078-0432.CCR-08-2004","volume":"15","author":"ME Mullendore","year":"2009","unstructured":"Mullendore ME, Koorstra JB, Li YM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009;15:2291\u2013301.","journal-title":"Clin Cancer Res"},{"key":"1072_CR26","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","volume":"67","author":"J Konishi","year":"2007","unstructured":"Konishi J, Kawaguchi KS, Vo H, et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res. 2007;67:8051\u20137.","journal-title":"Cancer Res"},{"key":"1072_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2016.11.017","volume":"386","author":"JY Jeong","year":"2017","unstructured":"Jeong JY, Kang H, Kim TH, et al. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3. Cancer Lett. 2017;386:168\u201378.","journal-title":"Cancer Lett"},{"key":"1072_CR28","doi-asserted-by":"crossref","first-page":"75118","DOI":"10.18632\/oncotarget.12611","volume":"7","author":"K Xu","year":"2016","unstructured":"Xu K, Shen K, Liang X, et al. MiR-139-5p reverses CD44+\/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget. 2016;7:75118\u201329.","journal-title":"Oncotarget"},{"key":"1072_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11060-012-1037-7","volume":"112","author":"L Chen","year":"2013","unstructured":"Chen L, Chen XR, Zhang R, et al. MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression. J Neuro-Oncol. 2013;112:59\u201366.","journal-title":"J Neuro-Oncol"},{"key":"1072_CR30","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1038\/ncomms8122","volume":"6","author":"P Zhu","year":"2015","unstructured":"Zhu P, Wang Y, Du Y, et al. C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nat Commun. 2015;6:7122.","journal-title":"Nat Commun"},{"key":"1072_CR31","doi-asserted-by":"publisher","first-page":"e44566","DOI":"10.1371\/journal.pone.0044566","volume":"7","author":"L Bauer","year":"2012","unstructured":"Bauer L, Langer R, Becker K, et al. Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and beta-catenin gene signature predicts survival. PLoS One. 2012;7:e44566.","journal-title":"PLoS One"},{"key":"1072_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.bbrc.2014.01.164","volume":"444","author":"J Liu","year":"2014","unstructured":"Liu J, Mao Z, Huang J, et al. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem Biophys Res Commun. 2014;444:670\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1072_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.7150\/jca.17741","volume":"8","author":"CY Chen","year":"2017","unstructured":"Chen CY, Chen YY, Hsieh MS, et al. Expression of Notch gene and its impact on survival of patients with resectable non-small cell lung cancer. J Cancer. 2017;8:1292\u2013300.","journal-title":"J Cancer"},{"key":"1072_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1158\/1078-0432.CCR-12-0370","volume":"19","author":"KA Hassan","year":"2013","unstructured":"Hassan KA, Wang L, Korkaya H, et al. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res. 2013;19:1972\u201380.","journal-title":"Clin Cancer Res"},{"key":"1072_CR35","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-14-2808","volume":"21","author":"WC Yen","year":"2015","unstructured":"Yen WC, Fischer MM, Axelrod F, et al. Targeting Notch signaling with a Notch2\/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Clin Cancer Res. 2015;21:2084\u201395.","journal-title":"Clin Cancer Res"},{"key":"1072_CR36","doi-asserted-by":"publisher","first-page":"17618","DOI":"10.1038\/srep17618","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang X, Chen X, Meng Q, et al. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGF\u03b2R1\/Smad signaling pathway in NSCLC. Sci Rep. 2015;5:17618.","journal-title":"Sci Rep"},{"key":"1072_CR37","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/sctm.17-0138","volume":"6","author":"F Papaccio","year":"2017","unstructured":"Papaccio F, Paino F, Regad T, et al. Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development. Stem Cells Transl Med. 2017;6:2115\u201325.","journal-title":"Stem Cells Transl Med"},{"key":"1072_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cllc.2014.06.010","volume":"16","author":"M Fasano","year":"2015","unstructured":"Fasano M, Della Corte CM, Capuano A, et al. A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial. Clin Lung Cancer. 2015;16:57\u20139.","journal-title":"Clin Lung Cancer"},{"key":"1072_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/CBM-170350","volume":"20","author":"Q Shi","year":"2017","unstructured":"Shi Q, Zhou Z, Ye N, et al. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1. Cancer Biomark. 2017;20:539\u20136.","journal-title":"Cancer Biomark"},{"key":"1072_CR40","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3892\/or.2013.2294","volume":"29","author":"G Pirozzi","year":"2013","unstructured":"Pirozzi G, Tirino V, Camerlingo R, et al. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep. 2013;29:1763\u20138.","journal-title":"Oncol Rep"},{"key":"1072_CR41","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s13277-014-2972-z","volume":"36","author":"P Huang","year":"2015","unstructured":"Huang P, Ye B, Yang Y, Shi J, Zhao H. MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. Tumour Biol. 2015;36:3381\u20137.","journal-title":"Tumour Biol"},{"key":"1072_CR42","first-page":"133","volume":"41","author":"M Caputi","year":"1997","unstructured":"Caputi M, De Luca L, Papaccio G, et al. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem. 1997;41:133\u20138.","journal-title":"Eur J Histochem"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-1072-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-1072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T21:52:43Z","timestamp":1605477163000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-1072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-1072-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each patient signed an informed consent form for medical record review and tissue sample donation. This study was approved by the Institutional Review Board at Harbin Medical University and was conducted according to all current ethics guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"327"}}